Gossamer Bio (GOSS) Return on Equity (ROE)

Price: $0.813
Market Cap: $184.73M
Avg Volume: 1.53M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.883
52W Range: $0.499-1.55
Website: Gossamer Bio

Return on Equity (ROE) Summary

Gossamer Bio's ROE measures the return generated on shareholders' equity:

  • Annual: -191.67%
  • Quarterly: -111.99%
  • TTM: -117.84%

What is Return on Equity (ROE)?

Return on Equity measures a company's ability to generate profits from its shareholders' equity. It indicates how effectively the management is using the company’s assets to create profits. A higher ROE generally reflects well on the company’s management and its ability to generate profits without needing as much capital.

Related Metrics

Other important metrics to assess Gossamer Bio's profitability include:

  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: -22.45%
    • Quarterly: -12.41%
    • TTM: -22.05%
  • ROA (Return on Assets) - measures the return generated on the company's assets:
    • Annual: -17.93%
    • Quarterly: -10.48%
    • TTM: -17.93%
  • Profit Margin - indicates the profitability of the company relative to its revenue:
    • Annual: -49.28%
    • Quarterly: -352.16%
    • TTM: -49.28%

These metrics provide insights into Gossamer Bio's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROE

-191.67%

Quarterly ROE

-111.99%

TTM ROE

-117.84%

Gossamer Bio Historical ROE
200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%-300.00%-300.00%ROE201720172018201820192019202020202021202120222022202320232024202420252025
Historical ROIC
200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%ROIC201720172018201820192019202020202021202120222022202320232024202420252025
Historical ROA
0.00%0.00%-400.00%-400.00%-800.00%-800.00%-1200.00%-1200.00%-1600.00%-1600.00%ROA201720172018201820192019202020202021202120222022202320232024202420252025

Gossamer Bio Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROE ROIC ROA Profit Margin
2024 -191.67% -22.45% -17.93% -49.28%
2023 -286.47% -66.76% -57.65% 0.00%
2022 23.27% -96.26% -88.17% 0.00%
2021 30.69% -75.01% -72.48% 0.00%
2020 43.56% -47.95% -46.64% 0.00%
2019 54.11% -47.61% -42.39% 0.00%
2018 122.40% -68.97% -61.39% 0.00%
2017 98.67% 166.24% -1521.57% 0.00%
2016 67.48% 0.00% -138.33% 0.00%

Related Metrics

Explore detailed financial metrics and analysis for GOSS.